Synthetic Biology Continues to Grow in the U.S., Raising More than $0.5B in 2015

In the past year, industrial applications for synthetic biology have simply exploded. Just in 2015, SynBio companies in the United States have raised more than half a billion dollars to advance fields as diverse as personalized medicine and next-generation textiles. The dramatic increase in synbio investment is primarily concentrated in two transcostal hubs: the greater San Francisco and Boston areas. Companies in San Francisco have benefitted from a very supportive startup culture, taking advantage of infrastructure laid down from years of Silicon Valley endeavours. The startup process has been streamlined in the area…Read more

What are the key factors to let Synthetic Biotechnology flourish in the UK?

The excitement in the synthetic biology community in the UK is palpable. It’s apparent in the buzz at SynBio meetings and conferences, but also evident by the sector’s rapid growth in the UK in the last five years. Thanks to the UK government’s pro-active mindset towards the industry - having identified SynBio as one of its seven key enabling technologies, it is perhaps the only country to have a coordinated and cohesive SynBio plan in place (in the form of the Synthetic Biology Roadmap). SynBio companies that set up shop in the UK…Read more

Crowdfunding platform Walacea launched to support scientific research projects

During the GapSummit 2014, the FundingGap was identified as one of the grand challanges for biotechnology toda, which is addressed by the science focused crowdfunding platform Walacea. Walacea is the first UK crowdfunding website set up specifically for crowdfunding scientific research projects. It was created in the wake of the government funding cuts for scientific research. After announcements from the Department of Business, Innovation and Skills (BIS) to slash scientific funding by £215m over two years, it seemed that scientific research was due to face some fairly serious setbacks. Our aim has been to…Read more